The Lancet, one of the world's top medical journals, on Thursday retracted an influential study that raised alarms about the safety of the experimental Covid-19 treatments chloroquine and hydroxychloroquine amid scrutiny of the data underlying the paper.
A pharmacy tech holds a bottle and a pill of Hydroxychloroquine at Rock Canyon Pharmacy in Provo, Utah, on May 20, 2020.that raised alarms about the safety of the experimental Covid-19 treatments chloroquine and hydroxychloroquine amid scrutiny of the data underlying the paper.
The retraction came at the request of the authors of the study, published last month, who were not directly involved with the data collection and sources, the journal said. "We can no longer vouch for the veracity of the primary data sources," Mandeep Mehra of Brigham and Women's Hospital, Frank Ruschitzka of University Hospital Zurich, and Amit Patel of University of Utah said in a statement. "Due to this unfortunate development, the authors request that the paper be retracted."
The retraction is sure to add fuel to contentious arguments about the potential of chloroquine and hydroxychloroquine, two old malaria drugs, in Covid-19, the disease caused by the novel coronavirus. President Trump has touted them as valuable treatments, despite a lack of rigorous data showing they have a benefit.of the first gold-standard clinical trial of hydroxycholoroquine in Covid-19, concluding that it did not prevent infections any better than placebo.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
$10 Billion Space Telescope May Be Delayed By Covid-19, Says NASANASA’s long-awaited James Webb Space Telescope (JWST) will likely miss its March 2021 target launch date due to Covid-19
Read more »
Cause of death: COVID-19, police violence or racism?Some public health experts are bracing for a spike in COVID-19 cases in the wake of protests against police brutality.
Read more »
Dentists extract new fee from patients to keep up with rising COVID-19 costsA growing number of dental offices across the country are charging patients an "infection control fee."
Read more »
Lyft Says Demand Picking Up as Covid-19 Restrictions EaseThe company said demand for rides climbed in recent weeks as people began venturing out following Covid-19 lockdowns but remains well below levels seen a year earlier.
Read more »
WHO committee recommends continued study of hydroxychloroquine as a potential Covid-19 treatmentThe coronavirus pandemic has brought countries to a standstill. Here's the latest updates on Covid-19 cases, deaths, government responses and more.
Read more »
After Reopening Schools, Israel Orders Them To Shut If COVID-19 Cases Are DiscoveredAt least 244 students and school employees have tested positive for the coronavirus in recent weeks, according to the education ministry. At least 130 cases occurred in a single school in Jerusalem.
Read more »